may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful
.
"i can't think of anything else where we have done that medically," van den veyver said.
.
advertisement
.
phil lempert: it's affordability. it's convenience. it's not having a lot of waste. people are more concerned about waste than ever before.
.